scispace - formally typeset
U

Uluhan Sili

Researcher at Marmara University

Publications -  60
Citations -  2206

Uluhan Sili is an academic researcher from Marmara University. The author has contributed to research in topics: Medicine & Cytotoxic T cell. The author has an hindex of 15, co-authored 44 publications receiving 1803 citations. Previous affiliations of Uluhan Sili include Istanbul University & Baylor College of Medicine.

Papers
More filters
Journal ArticleDOI

Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals.

TL;DR: Genetic modification of antigen-presenting cell lines are described to facilitate the production of CD4+ and CD8+ T lymphocytes specific for CMV, EBV and several serotypes of adenovirus from a single cell culture.
Journal ArticleDOI

Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies

TL;DR: DeltaLMP1 expression in DCs is nontoxic and enables the generation of LMP1-specific CTLs for future adoptive immunotherapy protocols for patients with L MP1-positive malignancies such as EBV-positive Hodgkin disease.
Journal ArticleDOI

Accelerated Production of Antigen-specific T Cells for Preclinical and Clinical Applications Using Gas-permeable Rapid Expansion Cultureware (g-rex)

TL;DR: Novel gas-permeable culture devices with a silicone membrane at the base allowing gas exchange to occur uninhibited by the depth of the medium above are evaluated, which effectively supports the expansion of CTL and actually increases output by up to 20-fold while decreasing the required technician time.
Journal ArticleDOI

Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses

TL;DR: It is demonstrated that allodepletion with an anti-CD25 immunotoxin following stimulation with HLA-mismatched host LCLs more consistently depleted in vitro alloreactivity than stimulation with host PBMCs, as assessed in primary mixed lymphocyte reactions (MLRs).
Journal ArticleDOI

Herpes simplex virus encephalitis: Clinical manifestations, diagnosis and outcome in 106 adult patients

TL;DR: Although HSVE fatality regressed considerably with acyclovir treatment, many patients survive with sequelae and the results emphasize the importance of early diagnosis and prompt treatment of HSVE.